These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9758329)

  • 1. Molecular basis of drug interaction with L-type Ca2+ channels.
    Mitterdorfer J; Grabner M; Kraus RL; Hering S; Prinz H; Glossmann H; Striessnig J
    J Bioenerg Biomembr; 1998 Aug; 30(4):319-34. PubMed ID: 9758329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of drug binding to L Ca2+ channels.
    Striessnig J; Grabner M; Mitterdorfer J; Hering S; Sinnegger MJ; Glossmann H
    Trends Pharmacol Sci; 1998 Mar; 19(3):108-15. PubMed ID: 9584627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
    Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
    Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology of high voltage-activated calcium channels.
    Doering CJ; Zamponi GW
    J Bioenerg Biomembr; 2003 Dec; 35(6):491-505. PubMed ID: 15000518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin.
    Ellinor PT; Zhang JF; Horne WA; Tsien RW
    Nature; 1994 Nov; 372(6503):272-5. PubMed ID: 7969473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of Voltage gated Calcium channels.
    Mohan CG; Gandhi T
    Mini Rev Med Chem; 2008 Oct; 8(12):1285-90. PubMed ID: 18855741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of ion permeation pathway in the N-type Ca2+ channel.
    Wakamori M; Strobeck M; Niidome T; Teramoto T; Imoto K; Mori Y
    J Neurophysiol; 1998 Feb; 79(2):622-34. PubMed ID: 9463426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures and functions of calcium channel beta subunits.
    Birnbaumer L; Qin N; Olcese R; Tareilus E; Platano D; Costantin J; Stefani E
    J Bioenerg Biomembr; 1998 Aug; 30(4):357-75. PubMed ID: 9758332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage inactivation of Ca2+ entry and secretion associated with N- and P/Q-type but not L-type Ca2+ channels of bovine chromaffin cells.
    Villarroya M; Olivares R; Ruíz A; Cano-Abad MF; de Pascual R; Lomax RB; López MG; Mayorgas I; Gandía L; García AG
    J Physiol; 1999 Apr; 516 ( Pt 2)(Pt 2):421-32. PubMed ID: 10087342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
    Li G; Hidaka H; Wollheim CB
    Mol Pharmacol; 1992 Sep; 42(3):489-8. PubMed ID: 1328847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular chaperone hsp70 interacts with the cytosolic II-III loop of the Cav2.3 E-type voltage-gated Ca2+ channel.
    Krieger A; Radhakrishnan K; Pereverzev A; Siapich SA; Banat M; Kamp MA; Leroy J; Klöckner U; Hescheler J; Weiergräber M; Schneider T
    Cell Physiol Biochem; 2006; 17(3-4):97-110. PubMed ID: 16543726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of voltage-gated Ca2+ channels by calmodulin.
    Halling DB; Aracena-Parks P; Hamilton SL
    Sci STKE; 2005 Dec; 2005(315):re15. PubMed ID: 16369047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion-channel modulators: more diversity than previously thought.
    Dilly S; Lamy C; Marrion NV; Liégeois JF; Seutin V
    Chembiochem; 2011 Aug; 12(12):1808-12. PubMed ID: 21726033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis.
    Peterson BZ; Johnson BD; Hockerman GH; Acheson M; Scheuer T; Catterall WA
    J Biol Chem; 1997 Jul; 272(30):18752-8. PubMed ID: 9228048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of voltage-dependent calcium channels.
    Mori Y; Mikala G; Varadi G; Kobayashi T; Koch S; Wakamori M; Schwartz A
    Jpn J Pharmacol; 1996 Oct; 72(2):83-109. PubMed ID: 8912911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation.
    Koschak A; Reimer D; Walter D; Hoda JC; Heinzle T; Grabner M; Striessnig J
    J Neurosci; 2003 Jul; 23(14):6041-9. PubMed ID: 12853422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.